Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02239640 · ClinicalTrials.gov registry record
Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry
A clinical trial, sponsored by Medtronic Neurovascular Clinical Affairs.
- Completed
- Registry status
- 984
- Enrollment target
NCT02239640: Completed study, sponsored by Medtronic Neurovascular Clinical Affairs.
NCT02239640 is a clinical trial that has completed, run by Medtronic Neurovascular Clinical Affairs. The registered enrollment target is 984 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02239640 has completed, sponsored by Medtronic Neurovascular Clinical Affairs.
- COMPLETED
- Registry status
- 984 participants
- Enrollment target
Study Summary
The purpose of this registry is to assess clinical outcomes, and different factors that may affect these clinical outcomes such as systems of care, associated with the use of Covidien market-released neurothrombectomy devices intended to restore blood flow in patients experiencing acute ischemic stroke due to large intracranial vessel occlusion.
Primary Outcome
Assess revascularization using modified Thrombolysis in Cerebral Infarction (mTICI) score at the end of the procedure. This scale determines the response of therapy for ischemic stroke based on angiographic appearances of the treated occluded vessel and the distal branches. Classification: grade 0: no perfusion grade 1: antegrade reperfusion past the initial occlusion, but limited distal branch filling with little or slow distal reperfusion grade 2a: antegrade reperfusion of less than half of
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 984 participants |
| Start Date | 2014-08-21 |
| Est. Completion | 2016-10-07 |
What the finished NCT02239640 record still lists
NCT02239640 is an observational study that tracks outcomes without assigning an intervention. The registered 984 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02239640 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02239640 about?
NCT02239640 is a clinical study titled "Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry". The purpose of this registry is to assess clinical outcomes, and different factors that may affect these clinical outcomes such as systems of care, associated with the use of Covidien market-released neurothrombectomy devices intended to restore blood flow in patients experiencing acute ischemic str...
What is the current status of trial NCT02239640?
This trial is currently completed. The enrollment target is 984 participants. The study started on 2014-08-21. Estimated completion is 2016-10-07.
Who is sponsoring clinical trial NCT02239640?
This trial is sponsored by Medtronic Neurovascular Clinical Affairs, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06989437 · 982 participants · Phase 2
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- NCT06959095 · 981 participants · Phase 3
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
- NCT05079841 · 988 participants · Phase 4
The Stimulation To Induce Mothers Study
- NCT06337097 · 980 participants · NA
STRICT - Surveillance With TRoponin During Immune Checkpoint Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI